Evelina Andrea Rondón-Abuhadba

Evelina Andrea Rondón-Abuhadba

Auto-generated profile, based on publicly available information

Evelina Andrea Rondón-Abuhadba

Universidad Nacional de San Antonio Abad del Cusco

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2019 in Medwave
Verified
Journal Article
Open access
MCMaycol Suker Ccorahua-Ríos
Maycol Suker Ccorahua-Ríos
NANoé Atamari-Anahui
Noé Atamari-Anahui
IMIveth Miranda-Abarca
Iveth Miranda-Abarca
ACAndy Bryan Campero-Espinoza
Andy Bryan Campero-Espinoza
EREvelina Andrea Rondón-Abuhadba
Evelina Andrea Rondón-Abuhadba
CPCésar Johan Pereira-Victorio
César Johan Pereira-Victorio
Type 2 diabetes mellitus is a health problem in low and middle-income countries like Peru. There are few published reports on trends and surveillance of this disease in the young Peruvian population. To describe the prevalence of type 2 diabetes mellitus in the population under 30 registered between 2005 and 2018 by the Ministry of Health of Peru. A descriptive study was conducted from a secondary analysis of the national registries of type 2 diabetes (ICD 10: E11) in the population under 30 treated in the health facilities of the Ministry of Health of Peru between 2015 and 2018. Described by department and geographic region, the prevalence of diabetes was adjusted for age and sex. In the period between 2005 and 2018, the national prevalence of type 2 diabetes mellitus increased from 2.1 to 22.1 cases/100 000 population. Women had a higher prevalence. Geographic regions with the highest prevalence increase were the Coast from 3.8 to 35.3/100 000 population and the Rainforest from 1.1 to 22.1/100 000 population. In the same period, the departments with the highest prevalence increase were Cajamarca (1733.3%) and Puno (1704.2%). Furthermore, Tumbes, Ica, Lambayeque, Callao, Lima, Loreto, and Madre de Dios reported prevalence rates over the national average. The prevalence of type 2 diabetes mellitus in the population under 30 and covered by the Peruvian Ministry of Health has increased more than ten times in the period between 2005 and 2018. The Coast and the cities with the highest population density had the highest prevalence. A greater focus to improve the strategies of risk factor control in the population under 30 is needed, including preventive actions on obesity and inadequate lifestyles, as well as a screening at a younger age for diabetes in the population at risk.

31 August 2020 in Medwave
Verified
Journal Article
Open access
NCNadin Melina Conto-Palomino
Nadin Melina Conto-Palomino
MCMaría Luz Cabrera-Bueno
María Luz Cabrera-Bueno
KVKenneth Grenis Vargas-Ponce
Kenneth Grenis Vargas-Ponce
EREvelina Andrea Rondón-Abuhadba
Evelina Andrea Rondón-Abuhadba
NANoé Atamari-Anahui
Noé Atamari-Anahui
There are limited reports of neurological symptoms in the pediatric population with COVID-19. We report a 13-year-old girl with three days of illness characterized by headache, non-explosive vomiting, fever, and sudden-onset sensory disorder associated with difficulty in standing and hemiparesis in limbs without evidence of meningeal signs. Brain tomography revealed diffuse brain edema, and the cerebrospinal fluid study was consistent with a viral infection. COVID-19 was diagnosed based on serology. The patient had an untoward clinical course despite treatment with hydroxychloroquine, azithromycin, and corticosteroids, dying on the third day of hospitalization. Encephalitis in a patient with COVID-19 is not frequently reported in the pediatric population. It should be considered in the differential diagnosis in patients who arrives at the emergency with a sensory disorder or neurological symptomatology in the context of the COVID-19 pandemic.

17 September 2020 in Medwave
Verified
Journal Article
Open access
NANoé Atamari-Anahui
Noé Atamari-Anahui
NCNelson Deyvis Cruz-Nina
Nelson Deyvis Cruz-Nina
MCMirian Condori-Huaraka
Mirian Condori-Huaraka
HNHéctor Nuñez-Paucar
Héctor Nuñez-Paucar
EREvelina Andrea Rondón-Abuhadba
Evelina Andrea Rondón-Abuhadba
CPCésar Johan Pereira-Victorio
César Johan Pereira-Victorio
Coronavirus disease 2019 has been reported in the pediatric population; however, there is limited information in Latin American and the Caribbean countries. To describe the frequency of cases, deaths, incidence, and case fatality rate attributed to COVID-19 in children and adolescents from Latin American and the Caribbean countries. An observational study was carried-out using COVID-19 case registries in children and adolescents published by the Ministries of Health of 19 countries in Latin American and the Caribbean countries until May 20, 2020. Cases and deaths were classified by sex and age group. Also, incidence and case fatality rates were calculated for each country. A total of 20,757 (4.2% of all patients) cases of COVID-19 were reported in children from 0 to 19 years of age. 52.4% was in the group aged 10 to 19 years. 50.6% were male. 139 (0.26%) deaths were reported in children from 0 to 19 years. The accumulated incidence was higher in Chile, Panama, and Peru. The cumulative incidence per 100,000 inhabitants ranged from 1.26 to 77.55 in the population from 0 to 9 years old, 1.57 to 98.84 from 10 to 19 years old, and 0.91 to 88.34 from 0 to 19 years old. The case fatality rate in children from 0 to 19 years old ranged from 0 to 9.09%. In 19 Latin American and the Caribbean countries, the frequency of cases, cumulative incidence, case fatality rate in children and adolescents was heterogeneous. These results contribute to understanding the epidemiological behavior of this disease in children and adolescents of the countries included in the study.

6 January 2020 in Journal of Pediatric Genetics
Verified
Journal Article
Closed access
PDF file
HAHugo Hernán Abarca-Barriga
Hugo Hernán Abarca-Barriga
MTMilana Trubnykova
Milana Trubnykova
FCFélix Chavesta-Velásquez
Félix Chavesta-Velásquez
CBClaudia Fiorella Barletta-Carrillo
Claudia Fiorella Barletta-Carrillo
MOMarco Ordoñez-Linares
Marco Ordoñez-Linares
ARAndrea Rondón-Abuhadba
Andrea Rondón-Abuhadba
Copy number variation in loss of 3p13 is an infrequently reported entity characterized by hypertelorism, aniridia, microphthalmia, high palate, neurosensorial deafness, camptodactyly, heart malformation, development delay, autism spectrum disorder, seizures, and choanal atresia. The entity is caused probably by haploinsufficiency for FOXP1, UBA3, FAM19A1, and MITF. We report a newborn male with hypotonia, facial dysmorphism, heart malformation, and without clinical diagnosis; nevertheless, the use of appropriate genetic test, such us the chromosomal microarray analysis allowed identification of a copy number variant in loss of 5.5 Mb at chromosome 3 (p13-p14.1), that included 54 genes, encompassing FOXP1 gene. We compare the findings in our Peruvian patient to those of earlier reported patients; furthermore, add new signs for this entity.

29 November 2018 in Medwave
Verified
Journal Article
Open access
CMChristian R. Mejia
Christian R. Mejia
LPLiz Paucar-Tito
Liz Paucar-Tito
LMLuz Morales-Concha
Luz Morales-Concha
NANoé Atamari-Anahui
Noé Atamari-Anahui
EREvelina Andrea Rondón-Abuhadba
Evelina Andrea Rondón-Abuhadba
MOMarco Edmundo Ordoñez-Linares
Marco Edmundo Ordoñez-Linares
Introduction Diabetic foot is one of the main complications of diabetes mellitus; however, in hospitals of provinces from Peru, the relationship of this condition with hospital stay has not been calculated. Objective To determine the association between hospitalization time and diabetic foot in three hospitals from Cusco, Peru. Methods A cross-sectional study of secondary data analysis was conducted. We analyzed the data of patients with type 2 diabetes mellitus admitted to the internal medicine service between January and December 2016, in three tertiary hospitals in Cusco, Peru. Correlation coefficients and p-values were calculated using generalized linear models, with Gaussian family and identity function, adjusted by intervening variables. Values of p < 0.05 were considered statistically significant. Results Of the 153 patients, 14% (21) had a diabetic foot diagnosis, and their median age was 61 years (interquartile range 56 to 68). Those who had a diabetic foot had on average 20 hospitalization days. A strong association was found between a diabetic foot and the number of hospitalization days (17 days more, p = 0.003); adjusted by six variables. Those patients with a history of hypertension had more hospitalization days (10 days more, p = 0.011) and those admitted to a hospital of the Ministry of Health, had fewer hospitalization days (10 days less, p = 0.032). Conclusion The group of patients with diabetic foot had a longer hospitalization time. The longer hospitalization time could be due to complications of the disease or difficulties in management.

6 June 2022 in Revista de la Facultad de Ciencias Médicas de Córdoba
Verified
Journal Article
Open access
PDF file
HAHugo Hernán Abarca-Barriga
Hugo Hernán Abarca-Barriga
FVFelix Chavesta Velásquez
Felix Chavesta Velásquez
CBClaudia Fiorella Barletta-Carrillo
Claudia Fiorella Barletta-Carrillo
ATAbel Paucarmayta Tacuri
Abel Paucarmayta Tacuri
MHMargaret Bazán Hurtado
Margaret Bazán Hurtado
EAEvelina Andrea Rondón Abuhadba
Evelina Andrea Rondón Abuhadba
Introducción. Las variantes en el número de copias son un tipo de cambios en el genoma provocan anomalías congénitas. Objetivo. Determinar las variantes en el número de copias y el grado de consanguinidad parental en neonatos con síndromes malformativos o una anomalía congénita mayor asociado a dismorfia facial o hipotonía. Material y métodos. Se realizó el análisis cromosómico por micromatrices a 60 neonatos con anomalías congénitas evaluados en los Hospitales Antonio Lorena y Regional de Cusco. Resultados. Del total de pacientes estudiados, el 70% tuvo un resultado anómalo; de los cuales en el 14,2% de los recién nacidos se encontraron variantes en el número de copias patogénicas o probablemente patogénicas asociadas o no a regiones de homocigosidad que tuvieron relación con las anomalías congénitas descritas. En el 48,3% de los recién se encontró regiones de homocigosidad mayores a 0,5% (coeficiente de endogamia superior a 1/64). Por otro lado, encontramos cinco variantes en el número de copias de patogenicidad desconocida que no se han descrito anteriormente y podrían estar relacionadas con el fenotipo. Conclusiones. Nuestra tasa de detección de las variantes en el número de copias está en relación con los reportes internacionales previos. Sin embargo, el porcentaje de neonatos con consanguinidad parental se encuentra por encima de lo reportado previamente, siendo superior a otras regiones de Sudamerica. Este es el primer reporte en el Perú, y es pionero en Latinoamérica al utilizar el análisis cromosómico por micromatrices en esta cohorte específica de pacientes.